ISOLATION AND CHARACTERIZATION OF SECONDARY METABOLITE FROM HABENARIA INTERMEDIA D. DON FOR SCREENING OF HEPATOPROTECITVE POTENTIAL AGAINST CARBON TETRACHLORIDE INDUCED TOXICITY IN ALBINO RAT LIVER

The purpose of the study was to isolate the coumarin glycoside constituent from the ethyl acetate fraction of tubers of Habenaria intermedia D. Don by column chromatography using the gradient elution technique. The isolated coumarin glycoside was characterized by spectral studies and screened for hepatoprotecitve potential on CCl4 induced toxicity in rat liver. The coumarin glycoside (Scopoletin) protective activity was evaluated by the assay of liver function biochemical parameters such as SGOT, SGPT, Bilirubin, total protein and histopathological studies of the liver. Results showed that the toxic effect of CCl4 was controlled significantly by restoration of the levels of serum bilirubin, proteins and enzymes as compared to the normal and standard drug Silymarin treated groups. Histology of the liver sections of the rats treated with isolated coumarin glycoside showed the presence of normal hepatic cords, absence of necrosis and fatty infiltration, which further substantiated hepatoprotecitve activity. Therefore, outcome of the present study ascertains that the isolated coumarin glycoside possesses significant hepatoprotecitve activity

The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy

In IgM paraproteinemia and peripheral neuropathy, IgM M-protein secretion by B cells leads to a T helper cell response, suggesting that it is antibody-mediated autoimmune disease involving carbohydrate epitopes in myelin sheaths. An immune response against sulfoglucuronosyl glycosphingolipids (SGGLs) is presumed to participate in demyelination or axonal degeneration in the peripheral nervous system (PNS). SGGLs contain a 3-sulfoglucuronic acid residue that interacts with anti-myelin-associated glycoprotein (MAG) and the monoclonal antibody anti-HNK-1. Immunization of animals with sulfoglucuronosyl paragloboside (SGPG) induced anti-SGPG antibodies and sensory neuropathy, which closely resembles the human disease. These animal models might help to understand the disease mechanism and lead to more specific therapeutic strategies. In an in vitro study, destruction or malfunction of the blood-nerve barrier (BNB) was found, resulting in the leakage of circulating antibodies into the PNS parenchyma, which may be considered as the initial key step for development of disease

Kinetic, mechanistic and thermodynamic aspects of lidocaine oxidation by chloramine-T in perchloric acid medium

The kinetics of lidocaine hydrochloride (LC) oxidation by sodium N-chloro p-toluenesulfonamide (CAT) in perchloric acid medium has been studied at 303K. The reaction stoichiometry was determined and oxidation products were identified. The reaction rate shows a first order dependence on CAT and fractional order on LC whereas inverse fractional order on H+. The products of reaction have no considerable effect on the rate. There is a slight negative effect by the dielectric constant. The rate remains same with the variation in the ionic strength of the medium indicating the involvement of non ionic species in rate determining step. There were no free radicals during the course of reaction. Kinetic runs were performed at different temperatures and thermodynamic parameters were computed. A mechanism consistent with observed parameters is proposed and rate law is derived

Synthesis and antimicrobial study of N-4-(2-piperidine-1-yl-ethoxy) phenyl acetamide analogues

In the present study, a novel series of N-4-(2-piperidine-1-yl-ethoxy) phenyl-acetamides were synthesized from 4-aminophenol and characterised by IR, 1H-NMR, Mass spectral studies and elemental analysis. The antimicrobial potency of compounds is tested against variety of fungal and bacterial strains by disc agar diffusion technique. in comparison to to fluconazole and chloramphenicol respectively. Some of the synthesized compounds exhibit the potency comparable to that of standard drugs

SYNTHESIS AND ASSESSMENT OF HEPATOPROTECITVE ACTIVITY OF SOME NEW 2-ARYL TETRAHYDROQUINOLINE AND SPIROOXYINDOLYL TETRAHYDROQUINOLINE DERIVATIVES

Objective: To evaluate the hepatoprotecitve potential of some newly synthesized tetrahydroquinoline derivatives against carbon tetrachloride induced hepatic damage in wister rats.Methods: A series of 2-aryl, 4-N vinyl pyrrolido/caprolacto and spirooxy indolyl tetrahydroquinolines were synthesized by imino Diels-Alder reaction using Antimony (III) sulfate as catalyst. The titled compounds were characterized by IR, 1HNMR spectroscopy and screened for hepatoprotecitve activity. Hepatopotoxicity was induced in male Wister rats by intrperitoneal injection of CCl4. Wister rats weighing 150-200g were randomly assigned in to various groups of six animals each. Group I – Normal control received only 1% Tween in distilled water, Group II – Served as negative control received CCl4 in liquid paraffin 1 ml/kg p. o. at every 72 h for 10 days. Group III – X were intoxicated with CCl4 1 ml/kg p. o. before the administration of Silymarin 100 mg/kg p. o. and suspension of synthetic derivatives in polyethylene glycol-400 at the dose of 25 mg/kg p. o. for 10 days. Different hepatic biochemical parameters viz. SGOT, SGPT, SALP, Total and direct bilirubin were evaluated before and after treatment to investigate the hepatoprotecitve activity.Results: It was observed that in CCl4 intoxicated group; total and direct bilirubin, SGOT, SGPT, SALP levels were significantly increased as compared to control group. Administration of synthesized tetrahydroquinoline derivatives at the dose of 25 mg/kg p. o. reduced these pathological damages caused by CCl4 intoxication compared to normal and Silymarin treated groups.Conclusion: The present study revealed that synthesized tetrahydroquinoline derivatives, showed hepatoprotecitve potential against CCl4 induced hepatotoxicity in wister rats, thus offering a novel synthetic formulation as a hepatoprotecitve drug.Â